Return to homepagePandemic Pact

Discovery and Development of Oral Small-molecule Direct-acting Antivirals

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N93025C00039-0-9999-1

Grant search

Key facts

  • Disease

    Ebola

  • Start & end year

    2025
    2026

  • Known Financial Commitments (USD)

    $1,999,195

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    CEO. SEAN EKINS

  • Research Location

    United States of America

  • Lead Research Institution

    COLLABORATIONS PHARMACEUTICALS, INC.

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The objective is to develop an oral treatment for Ebola virus infection in humans.